Search
Sunshine Biopharma Inc
SBFMAdd to Watchlist
0.906USD
-0.003-0.33%
Close 09-22 16:00（ET）
2.17MMarket Cap
LossP/E TTM
Sunshine Biopharma Inc (SBFM) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Sunshine Biopharma Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
56.000USD+6123.61%
SBFM Analyst Recommendation Trends
In the current month, SBFM has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SBFM average Analyst price target in the last month is 56.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
SBFM Analyst Rating for Peer Comparison
Updated: Sep 22, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
9
21
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Pfizer Inc
PFE
5
6
19
1
1
32
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
Forecast
--
--
--
Actual
-0.44
-2.54
-1.15
Surprise
--
--
--
FAQs
What is Sunshine Biopharma Inc's price target?
Analysts forecast that Sunshine Biopharma Inc's price target is USD 56.00, with the highest forecast at USD 56.00 and the lowest forecast at USD 56.00.
What is the analyst rating for Sunshine Biopharma Inc?
Based on the ratings of Sunshine Biopharma Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.